MedPath

An exploratory study on the curative effect of Xia's electrothermal needle in the treatment of chronic atrophic gastritis with intestinal metaplasia

Early Phase 1
Conditions
Chronic atrophic gastritis with intestinal metaplasia
Registration Number
ITMCTR2024000085
Lead Sponsor
Wangjing Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Meet the diagnostic criteria of chronic atrophic gastritis with intestinal metaplasia;
(2) Prior to enrollment, electronic gastroscopy and histopathology confirmed atrophy (reduced intrinsic glands) with mild or moderate enterosis (intestinal metaplasia), with or without mild or moderate dysplasia;
(2) Consistent with the TCM diagnosis and syndrome differentiation of chronic atrophic gastritis with intestinal metaplasia;
(3) Gender is not limited, age between 18 and 75 years old;
(4) The patient's informed consent and willingness to accept the appropriate treatment;
(5) Voluntary signing of informed consent.

Exclusion Criteria

(1) autoimmune gastritis;
(2) Patients with other serious complications such as malignant tumors;
(3) Gastric mucosa with high-grade intraepithelial neoplasia or suspected malignant transformation by pathological diagnosis;
(4) Those who are taking aspirin, warfarin and other anticoagulants, or have coagulation disorders;
(5) Patients with serious primary diseases such as heart, brain, liver, kidney, lung and blood system;
(6) Women who are lactating or even pregnant;
(7) Complicated with serious mental illness, unclear description of their own symptoms, unable to cooperate;
(8) Patients who are participating in clinical trials of other drugs.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath